Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (11), 3324-3328
- https://doi.org/10.1038/s41375-021-01176-7
Abstract
No abstract availableFunding Information
- Aplastic Anemia and MDS International Foundation
This publication has 11 references indexed in Scilit:
- SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDSBlood, 2020
- Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromesNature Communications, 2019
- Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasiaBlood Advances, 2019
- Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome ModulationCancer Cell, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblastsBlood, 2015
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsThe New England Journal of Medicine, 2011
- Frequent pathway mutations of splicing machinery in myelodysplasiaNature, 2011
- SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblastsLeukemia, 2011
- ASF/SF2-Regulated CaMKIIδ Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac MuscleCell, 2005